S. 2861 · 114th Congress
Post-Traumatic Stress Disorder Medication Prescribing Improvement Act of 2016
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 114th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
RoundsSponsorNo cosponsors.
Post-Traumatic Stress Disorder Medication Prescribing Improvement Act of 2016
What it does: CRS summary · Introduced in Senate · Apr 27, 2016
Post-Traumatic Stress Disorder Medication Prescribing Improvement Act of 2016
This bill directs the Department of Defense to: (1) review the prescribing practices at military treatment facilities of pharmaceutical agents for post-traumatic stress treatment, (2) implement a process or processes to monitor the prescribing practices at military treatment facilities of pharmaceutical agents that are discouraged from use under the VA/DOD Clinical Practice Guideline for Management of Post-Traumatic Stress, and (3) implement a plan to address deviations from such guideline.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Post-Traumatic Stress Disorder Medication Prescribing Improvement Act of 2016
Latest action (Apr 27, 2016): Read twice and referred to the Committee on Armed Services.
Policy area: Armed Forces and National Security · Origin: Senate · Introduced: Apr 27, 2016
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.